Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include HER2/EGFR in Cancer Research, Neuroblastoma Research and Treatments, PI3K/AKT/mTOR signaling in cancer, and Prostate Cancer Treatment and Research.
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
Ado-trastuzumab emtansine in patients with <i>HER2</i> amplified salivary gland cancers (SGCs): Results from a phase II basket trial.
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation
Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface
HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status
Effect of Phosphorylation on EGFR Dimer Stability Probed by Single-Molecule Dynamics and FRET/FLIM
c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer
Time‐domain microfluidic fluorescence lifetime flow cytometry for high‐throughput <scp>F</scp>örster resonance energy transfer screening